UNMC College of Medicine faculty brought in nine awards representing more than $1.1 million in new funding during the month of December. Here’s a rundown of these awards:
Peter Iwen, Ph.D., pathology and microbiology, has received more than $600,000 from the CDC through the Nebraska Department of Health and Human Services. These funds continue the support for bioterrorism preparedness research being done through the Nebraska Public Health Laboratory (NPHL) at UNMC.
Erika Boesen, Ph.D., cellular and integrative physiology, has received $300,000 in funding from the Lupus Research Institute. This award will support research into the effects of iron and chemical stress on certain structures within kidney cells affected by the autoimmune disorder.
John Colombo, M.D., pediatrics – pulmonology, has received more than $100,000 in renewed support from the Cystic Fibrosis Foundation for a therapeutics development center. The Nebraska Regional Cystic Fibrosis center provides diagnosis, treatment, and management of adult and pediatric cystic fibrosis, a chronic genetic disorder that affects mucus production primarily in the lungs.
Industry-sponsored grants:
The following industry-sponsored contracts and foundation grants were also received. Information on clinical trials enrolling patients at UNMC can be found here.
Hani Haider, Ph.D., orthopedic surgery, has received support from a New York University School of Medicine study on a novel unicompartmental knee replacement design.
James O’Dell, M.D., internal medicine – rheumatology, has received support from the University of Colorado to study how the immune system changes throughout rheumatoid arthritis development.
Duy Ha, an M.D./Ph.D. student in the department of cellular and integrative physiology, has received an award from the American Heart Association to study how scar formation in skeletal muscle tissue affects the development of peripheral artery disease.
Kevin Corley, M.D., pediatrics – endocrine, is the UNMC lead on a registry database developed to study the effects of Norditropin treatment of patients with growth hormone deficiencies.
Edward Truemper, M.D., pediatrics – critical care, is the UNMC lead in an international research study, the Approaches and Decisions in Acute Pediatric TBI (ADAPT) trial. The ADAPT trial aims to evaluate the impact of interventions on the outcomes of children with severe traumatic brain injury (TBI).
James Talmadge, Ph.D., pathology and microbiology, has received support to study the use of aqueous ozone, cold water infused with ozone gas, as an effective cleaner and disinfectant.